Covetrus, Inc. CVET
At closeOct 12, 2022, 4:00 PM EDT
52-week range unavailable
- Market cap
- 2.94B
- Revenue (ttm)
- 4.65B
- Profit margin
- -0.28%
- Shares out
- 140.12M
- Forward P/E
- 16.27
- Volume
- 5.30M
- Open
- 20.93
- Previous close
- 20.99
- Day's range
- 20.93 – 21.00
- Beta
- 1.51
- Analysts
- Hold
- Price target
- 22.00 (+4.8%)
- Earnings date
- Nov 3, 2022
2Y +1.88 (+9.84%)
Key statistics
- Enterprise value
- 4.07B
- PEG ratio
- 1.59
- Price / sales
- 0.63
- Price / book
- 1.95
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 2.40%
- Free cash flow
- 63.50M
- Total cash
- 87.00M
- Total debt
- 1.19B
- Return on equity
- -0.85%
- Short % of float
- 4.21%
- 50-day average
- 20.87
- 200-day average
- 18.85
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Next earnings
Nov 3, 2022
Expected Nov 3, 2022. Consensus EPS estimate 0.28.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2022 | Sep 1, 2022 | 0.27 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | 0.26 | — | — | — |
| May 5, 2022 | Mar 1, 2022 | 0.23 | — | — | — |
| Feb 24, 2022 | Dec 1, 2021 | 0.25 | — | — | — |
| Nov 4, 2021 | Sep 1, 2021 | 0.23 | — | — | — |
| Aug 5, 2021 | Jun 1, 2021 | 0.23 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 13, 2022 | Stifel | down | Buy | Hold |
| May 26, 2022 | Barclays | down | Overweight | Equal-Weight |
| May 25, 2022 | William Blair | down | Outperform | Market Perform |
| May 23, 2022 | Morgan Stanley | main | — | Equal-Weight |
| May 23, 2022 | Raymond James | down | Outperform | Market Perform |
| Aug 25, 2022 | Goldman Sachs | main | — | Sell |
About Covetrus, Inc.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- covetrus.com
News
FTC takes closer look at Cencora-Covetrus animal health merger, Bloomberg News reports
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal
Covetrus and MWI Animal Health to Merge
Covetrus Announces Agreement for Chewy to Acquire SmartEquine
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus Earnings Scheduled For August 4, 2022
CD&R, TPG Take Covetrus Private In $4B Deal
Covetrus going private in $4 billion deal
Covetrus to Be Taken Private for $4 Billion Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Your note
Sign in to keep a note on CVET — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FINER DUSTIN K | Officer | Conversion of Exercise of derivative security | May 31, 2022 | 89,370 |
| FONTEYNE PAUL R | Director | Conversion of Exercise of derivative security | Jun 30, 2022 | 13,275 |
| FOULSTON MATTHEW J | Chief Financial Officer | Conversion of Exercise of derivative security | Aug 31, 2022 | 95,079 |
| HELTON SANDRA LYNN | Director | Conversion of Exercise of derivative security | May 11, 2022 | 38,095 |
| KIDD REBECCA ANN | Officer | Conversion of Exercise of derivative security | Sep 29, 2022 | 20,028 |
| MALENFANT MATTHEW | Officer | Conversion of Exercise of derivative security | Aug 31, 2022 | 84,304 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 24.07% | 33,732,300 | 708.04M | Jun 29, 2022 |
| Blackrock Inc. | 12.15% | 17,030,965 | 357.48M | Jun 29, 2022 |
| Vanguard Group, Inc. (The) | 8.32% | 11,657,622 | 244.69M | Jun 29, 2022 |
| Wellington Management Group, LLP | 5.98% | 8,372,908 | 175.75M | Jun 29, 2022 |
| State Street Corporation | 2.77% | 3,878,419 | 81.41M | Jun 29, 2022 |
| Dimensional Fund Advisors LP | 2.20% | 3,084,639 | 64.75M | Jun 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 5.45% | 7,636,624 | 160.29M | Sep 29, 2022 |
| Vanguard Total Stock Market Index Fund | 2.21% | 3,093,818 | 64.94M | Jun 29, 2022 |
| Vanguard Small-Cap Index Fund | 1.88% | 2,639,423 | 55.40M | Jun 29, 2022 |
| iShares Russell 2000 ETF | 1.64% | 2,298,618 | 48.25M | Sep 29, 2022 |
| Vanguard Small Cap Value Index Fund | 1.24% | 1,743,499 | 36.60M | Jun 29, 2022 |
| iShares S&P Smallcap 600 Value ETF | 1.05% | 1,471,092 | 30.88M | Sep 29, 2022 |
